🏛️ Verified NIH Record • Updated 2026-05-29
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts (NCT06271291)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Mayo Clinic
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.
Who can join: Review the eligibility criteria below.
Location: HonorHealth Research Institute — Scottsdale, Arizona
Age range: 18 Years
🧪 Interventions in This Study
- Non-Interventional Study (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- HonorHealth Research Institute — Scottsdale, Arizona
- Piedmont Healthcare — Atlanta, Georgia
- OSF Saint Francis Medical Center — Peoria, Illinois
- The Johns Hopkins University School of Medicine — Baltimore, Maryland
- Dana-Farber Cancer Institute — Boston, Massachusetts
- Mayo Clinic in Rochester — Rochester, Minnesota
- University of Nebraska Medical Center — Omaha, Nebraska
- Oregon Health & Science University — Portland, Oregon
- University of Pittsburgh — Pittsburgh, Pennsylvania
📞 Contact the Study Coordinator
Phone: (855) 776-0015
Email: mayocliniccancerstudies@mayo.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pancreatic Carcinoma
- Pilot Study of Pancreatic Cancer Screening — San Francisco, California
- Use Of Indocyanine Green In Pancreas Surgery — Portland, Oregon
- Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer — Columbus, Ohio
- Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula — Birmingham, Alabama
Explore by condition: All Pancreatic Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.